Results 1 to 10 of about 38,429 (340)
Schwann cell Lrp1 deletion drives trigeminal neuron sensitization and orofacial pain by modulating mitochondrial function and TRPV1/TRPA1 activity. [PDF]
Gong Z +7 more
europepmc +2 more sources
Sleep apnea and orofacial pain: an integrative clinical perspective. [PDF]
Patil K, Puttaraju MK, Basavarajappa R.
europepmc +3 more sources
Effect of photobiomodulation therapy on painful temporomandibular disorders
To evaluate the effect of photobiomodulation therapy (PBMT) on painful temporomandibular disorders (TMD) patients in a randomized, double-blinded, placebo-controlled manner.
Adila Aisaiti +9 more
doaj +1 more source
Background Literature concerning Temporomandibular disorders (TMDs) and the Covid-19 pandemic is limited and disparate findings related to TMD frequencies, psychological distress, and quality of life were presented. This study investigated the prevalence
Adrian Ujin Yap +3 more
doaj +1 more source
Introduction A recent questionnaire-based study suggested that bruxism and painful temporomandibular disorders (TMD pain) may be more prevalent in patients with Parkinson’s disease (PD) compared with controls.
Henk W Berendse +4 more
doaj +1 more source
The application of acupuncture in the management of neuropathic orofacial pain: a narrative literature review. [PDF]
Pan D +5 more
europepmc +3 more sources
Differences in Botulinum Toxin Injection Into Temporal Muscles in Sleep Bruxism and Chronic Migraine [PDF]
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been used successfully to treat sleep bruxism (SB) and chronic migraine (CM). However, studies investigating injection protocols such as drug dosage
Jung Eun Lee +2 more
doaj +1 more source
This study aimed to evaluate the efficacy of botulinum toxin type A (BoNT/A) in patients with temporomandibular disorders (TMDs) associated with masticatory muscle pain (MMP) and headaches. This randomized, double-blind, placebo-controlled pilot study is
So Ra Kim +3 more
doaj +1 more source
Botulinum Toxin Injection for Managing Sleep Bruxism [PDF]
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been applied successfully to treat severe sleep bruxism (SB).
Seurin Kim +3 more
doaj +1 more source
Introduction: Gabapentinoids, pregabalin and gabapentin, neuronal voltage-gated calcium channel inhibitors are first-line treatments for painful neuropathic conditions (and several non-neuropathic painful conditions).
Sulukdjian Arek +3 more
doaj +1 more source

